当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Dr. Mika Wang
Enzyme-Linked Immunosorbent Assay (ELISA) is a widely used immunological technique that allows for the detection and quantification of specific antigens or antibodies in biological samples. It combines the principles of antigen-antibody binding with enzymatic amplification to generate measurable signals. ELISA has various formats, including indirect, direct, sandwich, and competitive ELISA, each with its advantages and limitations. This article provides an overview of the principle, types, and applications of ELISA, as well as the factors influencing its performance. ELISA is a crucial tool in immunological research and diagnostic applications, contributing to disease diagnosis, biomarker discovery, drug development, and vaccine development. The emerging trends in ELISA technology, such as microfluidic platforms and multiplexing capabilities, are also discussed. ELISA continues to play a pivotal role in advancing our understanding of immunology and improving healthcare outcomes.